Skip to main content

© 2026 Verity by Backwork. All rights reserved.

Q5128 - HCPCS Level II | Verity

Home/Codes/HCPCS Level II/Q5128

HCPCS Level IItemporaryActive

Q5128

Inj, cimerli, 0.1 mg

BETOS: O1E

Effective: 2023-04-01

Referenced in 1 policies

Description

Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg

Medicare Fee Schedule

2026 Medicare Physician Fee Schedule national payment rates

Excluded

This code is excluded from the Medicare Physician Fee Schedule.

Coverage Policies

This code is referenced in 1 Medicare coverage policy

Sample Policies

A52451Articlecovered

Billing and Coding: Ranibizumab and biosimilars, Aflibercept, Aflibercept HD, Brolucizumab-dbll, Faricimab-svoa, PAVBLUaflibercept-ayyh, AHZANTIVE®aflibercept-abzv. ENZEEVUaflibercept-mrbb, OPUVIZaflibercept-yszy and YESAFILI aflibercept-jbvf

View All Coverage Details

Sign up for free to see all 1 policies and full coverage criteria

About HCPCS Level II

Healthcare Common Procedure Coding System Level II codes for supplies, equipment, and non-physician services

Unlock Full Coverage Intelligence

See which policies cover this code, disposition status, and coverage criteria

Sign Up Free Already have an account? Log in

What You Get with Verity

✓Coverage policy linkage
✓Disposition status per policy
✓Full coverage criteria text
✓Policy change alerts
✓API access for integrations

Browse More Codes

HCPCS Codes ICD-10-CM Diagnosis Codes ICD-10-PCS Procedure Codes